Skip to Main Content

WASHINGTON — He’s one of the richest men in the world. He’s sought to eradicate malaria, pledged $10 billion to help fund childhood vaccinations, and poured another $3 billion into fighting HIV. But Bill Gates has been far more restrained in bankrolling research into Alzheimer’s disease.

One of the first investments made by the billionaire’s Gates Ventures was in the Dementia Discovery Fund, which invests in novel science. But, all told, Gates’ Alzheimer’s investments only total roughly $100 million, which even Gates’ chief science adviser, Niranjan Bose, acknowledges is a “drop in the bucket.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Nicholas,
    Money/funding for basic research on Alzheimer’s disease is precisely the issue. AD research for decades has been less than 1% of the NIH budget, which itself is grossly inadequate. We are in the current situation because we have not invested in basic research in AD. No research/science, no progress. Mr Gates should know this well enough. He has just gotten some bad advice. If Mr Gates wants to make a difference in AD, it will take at least $5B/year in basic research for at least 10 years. BTW, the NIH budget should be $150B not $39B. That is what is needed to be globally competitive. For the second year in a row, the Chinese NIH is the top research institution in the world. In 1999 the NIH budget was $30B, now 20 years later it is $39B, with inflation alone it should be $45B so it is -13%. Military budget in 1999 was $298B now it is $643B, +43% above inflation. The US is obviously not the healer of the world.
    Ernest Villafranca

Comments are closed.